Molecular characterization of glioma patient-derived orthotopic xenografts: from basic research to preclinical studies

Ann-Christin Hau; Anna Golebiewska; Anais Oudin; Linsey Houben; Daniel Stieber; Francisco Azuaje; Tony Kaoma; Arnaud Muller; Frank Hertel; Michel Mittelbronn; Rolf Bjerkvig; Simone Niclou

doi:10.1093/neuonc/noy148.1141

Molecular characterization of glioma patient-derived orthotopic xenografts: from basic research to preclinical studies

Ann-Christin Hau, Anna Golebiewska, Anais Oudin, Linsey Houben, Daniel Stieber, Francisco Azuaje, Tony Kaoma, Arnaud Muller, Frank Hertel, Michel Mittelbronn, Rolf Bjerkvig, Simone Niclou

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	TMOD-29
Pages (from-to)	274-275
Journal	Neuro-Oncology
Volume	20
Issue number	Suppl.6
DOIs	https://doi.org/10.1093/neuonc/noy148.1141
Publication status	Published - Nov 2018
Event	23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference - New Orleans, United States Duration: 4 Nov 2018 → 18 Nov 2018

Access to Document

10.1093/neuonc/noy148.1141Licence: Unspecified

Cite this

Hau, A.-C., Golebiewska, A., Oudin, A., Houben, L., Stieber, D., Azuaje, F., Kaoma, T., Muller, A., Hertel, F., Mittelbronn, M., Bjerkvig, R., & Niclou, S. (2018). Molecular characterization of glioma patient-derived orthotopic xenografts: from basic research to preclinical studies. Neuro-Oncology, 20(Suppl.6), 274-275. Article TMOD-29. https://doi.org/10.1093/neuonc/noy148.1141

@article{dc4f71400c6743b5a682953121fcc866,

title = "Molecular characterization of glioma patient-derived orthotopic xenografts: from basic research to preclinical studies",

author = "Ann-Christin Hau and Anna Golebiewska and Anais Oudin and Linsey Houben and Daniel Stieber and Francisco Azuaje and Tony Kaoma and Arnaud Muller and Frank Hertel and Michel Mittelbronn and Rolf Bjerkvig and Simone Niclou",

year = "2018",

month = nov,

doi = "10.1093/neuonc/noy148.1141",

language = "English",

volume = "20",

pages = "274--275",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "Suppl.6",

note = "23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference ; Conference date: 04-11-2018 Through 18-11-2018",

}

Hau, A-C, Golebiewska, A , Oudin, A, Houben, L, Stieber, D, Azuaje, F, Kaoma, T, Muller, A, Hertel, F, Mittelbronn, M, Bjerkvig, R & Niclou, S 2018, 'Molecular characterization of glioma patient-derived orthotopic xenografts: from basic research to preclinical studies', Neuro-Oncology, vol. 20, no. Suppl.6, TMOD-29, pp. 274-275. https://doi.org/10.1093/neuonc/noy148.1141

TY - JOUR

T1 - Molecular characterization of glioma patient-derived orthotopic xenografts: from basic research to preclinical studies

AU - Hau, Ann-Christin

AU - Golebiewska, Anna

AU - Oudin, Anais

AU - Houben, Linsey

AU - Stieber, Daniel

AU - Azuaje, Francisco

AU - Kaoma, Tony

AU - Muller, Arnaud

AU - Hertel, Frank

AU - Mittelbronn, Michel

AU - Bjerkvig, Rolf

AU - Niclou, Simone

PY - 2018/11

Y1 - 2018/11

U2 - 10.1093/neuonc/noy148.1141

DO - 10.1093/neuonc/noy148.1141

M3 - Meeting Abstract

SN - 1522-8517

VL - 20

SP - 274

EP - 275

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Suppl.6

M1 - TMOD-29

T2 - 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference

Y2 - 4 November 2018 through 18 November 2018

ER -